| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 15.73 Billion | USD 73.41 Billion | 16.8% | 2024 |
FrequentlyAsked Questions
Epigenetics is the study of how gene expression is regulated without changing the actual DNA sequence . simpler terms: Your genes don’t change, but how active or inactive they are can change—based on environment, lifestyle, and other factors . That’s epigenetics
The Global epigenetics market is expected to grow due to increasing research in gene expression, rising adoption of personalized medicine, and growing investments in epigenetic drug development.
According to a study, the Global epigenetics market size was worth around USD 15.73 Billion in 2024 and is expected to reach USD 73.41 Billion by 2034.
The Global epigenetics market is expected to grow at a CAGR of 16.8% during the forecast period.
North America is expected to dominate the epigenetics market over the forecast period.
Leading players in the Global epigenetics market include Hologic Inc., Agilent Technologies Inc., Merck Millipore, PerkinElmer Inc., QIAGEN N.V., Illumina Inc., Thermo Fisher Scientific Inc., Abcam Plc., Zymo Research, and Active Motif Inc., among others., among others.
The report explores crucial aspects of the epigenetics market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients